Cargando…
Improving ovarian cancer treatment decision using a novel risk predictive tool
Background: As a major component of the tumor tissue, the tumor microenvironment (TME) has been proven to associate with tumor progression and immunotherapy. Ovarian cancer accounts for the highest mortality rate among gynecologic malignancies. Its clinical treatment decision is highly correlated wi...
Autores principales: | Xu, Zhenyi, Song, Jiali, Cao, Lei, Rong, Zhiwei, Zhang, Wenjie, He, Jia, Li, Kang, Hou, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9085236/ https://www.ncbi.nlm.nih.gov/pubmed/35439731 http://dx.doi.org/10.18632/aging.204023 |
Ejemplares similares
-
Mediation Analysis Reveals Potential Biological Mechanism of Ascites Influencing Recurrence in Patients with Epithelial Ovarian Cancer
por: Yang, Chunyan, et al.
Publicado: (2020) -
The Discovery of New Drug-Target Interactions for Breast Cancer Treatment
por: Song, Jiali, et al.
Publicado: (2021) -
HiRAND: A novel GCN semi-supervised deep learning-based framework for classification and feature selection in drug research and development
por: Huang, Yue, et al.
Publicado: (2023) -
An Immunophenotyping of Ovarian Cancer With Clinical and Immunological Significance
por: Yang, Kai, et al.
Publicado: (2018) -
Identification of a six-lncRNA signature associated with recurrence of ovarian cancer
por: Yang, Kai, et al.
Publicado: (2017)